Jonathan C. Meltzer - 10 Feb 2026 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)

Reporting relationship: EVP, Operations
Issuer ticker: LH
Reported as of: 10 Feb 2026
Net transaction value: -$25,188
SEC form: 4
Accepted by SEC: 12 Feb 2026, 15:44:53 UTC
Prior SEC filing: 10 Feb 2026
Next SEC filing: 13 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Kathryn W. Kyle, Attorney-in-Fact for Jonathan C. Meltzer

Key filing fact

Jonathan C. Meltzer filed Form 4 for LABCORP HOLDINGS INC. (LH) on 12 Feb 2026.

Key facts

This page summarizes Jonathan C. Meltzer's Form 4 filing for LABCORP HOLDINGS INC. (LH).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 12 Feb 2026, 15:44.

Change

Previous filing in this sequence was filed on 10 Feb 2026.
Current net transaction value: -$25,188.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002103998 Primary reporting owner

Meltzer Jonathan C

Relationship: EVP, Operations
Address: 531 SOUTH SPRING STREET, BURLINGTON
Signature: /s/ Kathryn W. Kyle, Attorney-in-Fact for Jonathan C. Meltzer
Signature date: 12 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LH transaction

Common Stock

Sale

Transaction value: $25,188
Shares: -91
Change %: -3.3%
Price: $276.79
Shares after: 2,696
Date: 10 Feb 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LH transaction Derivative

Non-qualified Stock Options

Award

Transaction value: $0
Shares: +1,900
Change %
Price: $0.000000
Shares after: 1,900
Date: 10 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,900
Exercise price: $284.50
Footnotes: F2, F3

LH transaction Derivative

Restricted Stock Unit

Award

Transaction value: $0
Shares: +620
Change %: +27%
Price: $0.000000
Shares after: 2,937
Date: 10 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 620
Exercise price
Footnotes: F4, F5, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Footnote F2

Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan.

Footnote F3

The option vests in three equal annual installments beginning on the date reflected in this column.

Footnote F4

Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

Footnote F5

The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027.

Footnote F6

This number reflects the aggregate number of Restricted Stock Units held by the reporting person.